Next-generation imaging in the management of advanced prostate cancer

Posted on April 5, 2019 by Sitemaster

A new article in the most recent issue of the Journal of Urology provides recommendations for clinicians as to the appropriate, current use of “next-generation” imaging in the treatment of advanced prostate cancer. … READ MORE …

Filed under: Uncategorized | Tagged: , , , , | 7 Comments »

Over- and under-imaging of newly diagnosed prostate cancer patients

Posted on February 20, 2011 by Sitemaster

This is hardly a radical new finding but yet another study has recently shown that we are over-using expensive scanning tests in the work-up of patients diagnosed with low- and intermediate-risk prostate cancer — and under-using these tests in men initially diagnosed with high-risk disease. … READ MORE …

Filed under: Diagnosis, Management, Risk | Tagged: , , , , | 1 Comment »

More on PET scans and their role in prostate cancer detection

Posted on January 2, 2010 by Sitemaster

A few days ago we suggested that the role of positron emission tomography (PET scanning) as a diagnostic and prognostic tool in patients with prostate cancer was probably best limited to research studies at major medical centers at the present time. A recent study from Germany appears to confirm this suggestion. … READ MORE …

Filed under: Diagnosis, Management, Risk | Tagged: , , | 3 Comments »

The Wednesday news reports: March 18, 2009

Posted on March 18, 2009 by Sitemaster

Today we cover reports on:

  • The incidence of prostate cancer among older HIV-positive men
  • ARTS and the potential of dutasteride in treatment of patients with biochemical recurrence
  • PET scans and their use in detection of biochemical recurrence
  • Chemotherapy in treatment of prostate cancer … READ MORE …

Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment, Uncategorized | Tagged: , , , , , | Leave a comment »